Center for Scientific Review; Notice of Closed Meetings, 26489-26490 [2018-12174]

Download as PDF Federal Register / Vol. 83, No. 110 / Thursday, June 7, 2018 / Notices National Institutes of Health National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Mental Health Special Emphasis Panel; NIMH Psychoactive Drug Screening Program (PDSP). Date: June 19, 2018. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Vinod Charles, Ph.D., Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6151, MSC 9606, Bethesda, MD 20892–9606, 301–443–1606, charlesvi@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: May 31, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–12176 Filed 6–6–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES sradovich on DSK3GMQ082PROD with NOTICES National Institutes of Health End of the Call for Participation for Computational Photography Project for Pill Identification (C3PI) AGENCY: National Institutes of Health, With the successful completion of the 2016 Pill Image Recognition Challenge, the National Library of Medicine (NLM) gratefully acknowledges the pharmaceutical manufacturers, re-packagers, wholesalers, and retail and institutional pharmacies that submitted prescription drug products for imaging as part of its Computational Photography Project for Pill Identification (C3PI). Effective immediately, the NLM is concluding its collection of digital imagery of C3PI oral solid dosage formulations (OSDFs), discontinuing the program, and is no longer accepting prescription drug products for photography. SUMMARY: DEPARTMENT OF HEALTH AND HUMAN SERVICES Any question regarding C3PI and its discontinuation should be sent to: Dr. Terry Yoo at splimage@nlm.nih.gov, 301–827–4976. FOR FURTHER INFORMATION CONTACT: C3PI developed information infrastructure and computational tools for identifying pills from digital photographs and associated data. C3PI issued a Pill Image Recognition (PIR) computer vision challenge in January 2016, seeking software solutions for the content-based information retrieval of drug information from images submitted as queries. NLM quantitatively evaluated the resulting entries and awarded prizes to the winners. The findings from the PIR challenge were published in October 2016. See https:// www.ncbi.nlm.nih.gov/pmc/articles/ PMC5973812/. NLM is ending the project. No future prescription drug products will be accepted. Digital images will not be obtained of drug products that may have been submitted but not photographed as of the termination of this project. Previous NLM Imaging Initiative Superseded: This notice supersedes all prior instructions provided by 79 FR 56381–56382 https:// www.federalregister.gov/documents/ 2014/09/19/2014-22308/call-forparticipation-for-computationalphotography-project-for-pillidentification-c3pi, published on September 19, 2014. SUPPLEMENTARY INFORMATION: Dated: June 1, 2018. Patricia Brennan, Director, National Library of Medicine, National Institutes of Health. [FR Doc. 2018–12273 Filed 6–6–18; 8:45 am] BILLING CODE 4140–01–P HHS. ACTION: Notice. VerDate Sep<11>2014 17:19 Jun 06, 2018 Jkt 244001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 26489 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Nursing Research; Notice to Close Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Nursing Research Initial Review Group. Date: June 21, 2018. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Weiqun Li, MD, Scientific Review Officer, National Institute of Nursing Research, National Institutes of Health, 6701 Democracy Blvd., Suite 710, Bethesda, MD 20892, (301) 594–5966, wli@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS) Dated: June 1, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–12177 Filed 6–6–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant E:\FR\FM\07JNN1.SGM 07JNN1 26490 Federal Register / Vol. 83, No. 110 / Thursday, June 7, 2018 / Notices sradovich on DSK3GMQ082PROD with NOTICES applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Medical Imaging Investigations. Date: June 29, 2018. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Songtao Liu, MD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5118, Bethesda, MD 20817, 301–827–6828, songtao.liu@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Dermatology, Rheumatology and Inflammation. Date: July 6, 2018. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt at Olive 8, 1635 8th Avenue, Seattle, WA 98275. Contact Person: Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301–435–1212, kumarra@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Role of Microbiome in the Developmental Origins of Health and Disease. Date: July 6, 2018. Time: 8:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites by Hilton Washington DC Chevy Chase, Embassy Suites by Hilton Washington DC Chevy Chase, 4300 Military Road, Washington, DC 20015. Contact Person: Meenakshisundar Ananthanarayanan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2178, Bethesda, MD 20892, 301– 827–6281, meena.ananthanarayanan@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR16–274/ 275: Serious Adverse Drug Reaction Research. Date: July 6, 2018. Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Alexander D Politis, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 20892, (301) 435– 1150, politisa@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Dermatology and Autoimmune Diseases. Date: July 6, 2018. VerDate Sep<11>2014 17:19 Jun 06, 2018 Jkt 244001 Time: 1:00 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt at Olive 8, 1635 8th Avenue, Seattle, WA 98275. Contact Person: Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301–435–1212, kumarra@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 1, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–12174 Filed 6–6–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2018–0453] Certificate of Alternative Compliance for the M/V SAMANTHA S Coast Guard, DHS. Notification of issuance of a certificate of alternative compliance. AGENCY: ACTION: The Coast Guard announces that the Chief, Prevention Division, Thirteenth District has issued a certificate of alternative compliance from the International Regulations for Preventing Collisions at Sea, 1972 (72 COLREGS), for the M/V SAMANTHA S (O.N. 1283014). We are issuing this notice because its publication is required by statute. Due to the construction and placement of the towing gear, deck equipment and required lights, the M/V SAMANTHA S cannot fully comply with the light, shape, or sound signal provisions of the 72 COLREGS without interfering with the vessel’s design and construction. This notification of issuance of a certificate of alternative compliance promotes the Coast Guard’s marine safety mission. DATES: The Certificate of Alternative Compliance was issued on May 31, 2018. FOR FURTHER INFORMATION CONTACT: For information or questions about this notice call or email LT B. Luke Woods, Thirteenth District, U.S. Coast Guard; telephone 206–220–7232, email Bert.L.Woods@uscg.mil@uscg.mil. SUPPLEMENTARY INFORMATION: The United States is signatory to the SUMMARY: PO 00000 Frm 00081 Fmt 4703 Sfmt 9990 International Maritime Organization’s International Regulations for Preventing Collisions at Sea, 1972 (72 COLREGS), as amended. The special construction or purpose of some vessels makes them unable to comply with the light, shape, or sound signal provisions of the 72 COLREGS. Under statutory law 1 and Coast Guard regulation,2 the vessel’s owner, builder, operator, or agent of those vessels may apply for a certificate of alternative compliance (COAC).3 For vessels of special construction, the cognizant Coast Guard District Office determines whether the vessel for which the COAC is sought complies as closely as possible with the 72 COLREGS, and decides whether to issue the COAC which must specify the required alternative installation. If the Coast Guard issues a COAC, under the governing statute 4 and regulations,5 the Coast Guard must publish notice of this action. Once issued, a COAC remains valid until information supplied in the COAC application or the COAC terms become inapplicable to the vessel. The Chief, Prevention Division, of the Thirteenth Coast Guard District, U.S. Coast Guard, certifies that the M/V SAMANTHA S (O.N. 1283014) is a vessel of special construction or purpose, and that, with respect to the position of the sternlight, towing light and sidelights, it is not possible to comply fully with the requirements of the provisions enumerated in the 72 COLREGS, without interfering with the normal operation, construction, or design of the vessel. The Chief, Prevention Division, of the Thirteenth Coast Guard District, U.S. Coast Guard further finds and certifies that the sternlight, towing light and sidelights, are in the closest possible compliance with the applicable provisions of the 72 COLREGS.6 This notice is issued under authority of 33 U.S.C. 1605(c) and 33 CFR 81.18. Dated: May 31, 2018. D.L. Brown, Commander, U.S. Coast Guard, Acting Chief, Prevention Division, Thirteenth Coast Guard District. [FR Doc. 2018–12288 Filed 6–6–18; 8:45 am] BILLING CODE 9110–04–P 1 33 U.S.C. 1605(c). CFR 81.3. 3 33 CFR 81.5. 4 33 U.S.C. 1605(c). 5 33 CFR 81.18. 6 33 U.S.C. 1605(a); 33 CFR 81.9. 2 33 E:\FR\FM\07JNN1.SGM 07JNN1

Agencies

[Federal Register Volume 83, Number 110 (Thursday, June 7, 2018)]
[Notices]
[Pages 26489-26490]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12174]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant

[[Page 26490]]

applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Medical Imaging Investigations.
    Date: June 29, 2018.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Songtao Liu, MD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5118, Bethesda, MD 20817, 301-827-6828, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business: Dermatology, Rheumatology and Inflammation.
    Date: July 6, 2018.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt at Olive 8, 1635 8th Avenue, Seattle, WA 98275.
    Contact Person: Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for 
Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301-435-1212, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Role of Microbiome in the Developmental Origins of Health and 
Disease.
    Date: July 6, 2018.
    Time: 8:00 a.m. to 6:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites by Hilton Washington DC Chevy Chase, 
Embassy Suites by Hilton Washington DC Chevy Chase, 4300 Military 
Road, Washington, DC 20015.
    Contact Person: Meenakshisundar Ananthanarayanan, Ph.D., 
Scientific Review Officer, Center for Scientific Review, National 
Institutes of Health, 6701 Rockledge Drive, Room 2178, Bethesda, MD 
20892, 301-827-6281, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR16-274/275: Serious Adverse Drug Reaction Research.
    Date: July 6, 2018.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Alexander D Politis, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3210, MSC 7808, Bethesda, MD 
20892, (301) 435-1150, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Dermatology and Autoimmune Diseases.
    Date: July 6, 2018.
    Time: 1:00 p.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt at Olive 8, 1635 8th Avenue, Seattle, WA 98275.
    Contact Person: Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for 
Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301-435-1212, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: June 1, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-12174 Filed 6-6-18; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.